These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 29057641)
1. Anti-Vascular Endothelial Growth Factor Therapy for Myopic Choroidal Neovascularization. Ng DSC; Lai TYY; Cheung CMG; Ohno-Matsui K Asia Pac J Ophthalmol (Phila); 2017; 6(6):554-560. PubMed ID: 29057641 [TBL] [Abstract][Full Text] [Related]
2. Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization. Sayanagi K; Uematsu S; Hara C; Wakabayashi T; Fukushima Y; Sato S; Ikuno Y; Nishida K Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):749-757. PubMed ID: 30643966 [TBL] [Abstract][Full Text] [Related]
3. CHOROIDAL THICKNESS AND CHORIORETINAL ATROPHY IN MYOPIC CHOROIDAL NEOVASCULARIZATION WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. Lee JH; Lee SC; Kim SH; Koh HJ; Kim SS; Byeon SH; Lee CS Retina; 2017 Aug; 37(8):1516-1522. PubMed ID: 27798519 [TBL] [Abstract][Full Text] [Related]
4. CORRESPONDENCE OF LEAKAGE ON FLUORESCEIN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS IN DIAGNOSIS AND MONITORING OF MYOPIC CHOROIDAL NEOVASCULARIZATION TREATED WITH BEVACIZUMAB. Battaglia Parodi M; Iacono P; Bandello F Retina; 2016 Jan; 36(1):104-9. PubMed ID: 26166803 [TBL] [Abstract][Full Text] [Related]
5. APPLICATION OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY TO ASSESS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN MYOPIC CHOROIDAL NEOVASCULARIZATION. Cheng Y; Li Y; Huang X; Qu Y Retina; 2019 Apr; 39(4):712-718. PubMed ID: 29256987 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor gene and the response to anti-vascular endothelial growth factor treatment for choroidal neovascularization in high myopia. Miyake M; Yamashiro K; Akagi-Kurashige Y; Kumagai K; Nakata I; Nakanishi H; Oishi A; Tsujikawa A; Yamada R; Matsuda F; Yoshimura N Ophthalmology; 2014 Jan; 121(1):225-233. PubMed ID: 23953100 [TBL] [Abstract][Full Text] [Related]
7. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization. Ahn SJ; Park KH; Woo SJ Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5794-800. PubMed ID: 26325418 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab. Yang HS; Kim JG; Kim JT; Joe SG Am J Ophthalmol; 2013 Dec; 156(6):1201-1210.e2. PubMed ID: 24075429 [TBL] [Abstract][Full Text] [Related]
10. Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization. Oishi A; Yamashiro K; Tsujikawa A; Ooto S; Tamura H; Nakata I; Miyake M; Yoshimura N Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):1-7. PubMed ID: 22527326 [TBL] [Abstract][Full Text] [Related]
11. Fluorescein angiography and spectral-domain optical coherence tomography for monitoring anti-VEGF therapy in myopic choroidal neovascularization. Iacono P; Battaglia Parodi M; Papayannis A; Kontadakis S; Da Pozzo S; Cascavilla ML; La Spina C; Varano M; Bandello F Ophthalmic Res; 2014; 52(1):25-31. PubMed ID: 24861045 [TBL] [Abstract][Full Text] [Related]
12. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy. Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hayashi W; Yoshida T; Tokoro T; Mochizuki M Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991 [TBL] [Abstract][Full Text] [Related]
13. Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management. Cheung CMG; Arnold JJ; Holz FG; Park KH; Lai TYY; Larsen M; Mitchell P; Ohno-Matsui K; Chen SJ; Wolf S; Wong TY Ophthalmology; 2017 Nov; 124(11):1690-1711. PubMed ID: 28655539 [TBL] [Abstract][Full Text] [Related]
15. Features of optical coherence tomography predictive of choroidal neovascularisation treatment response in pathological myopia in association with fluorescein angiography. Lee DH; Kang HG; Lee SC; Kim M Br J Ophthalmol; 2018 Feb; 102(2):238-242. PubMed ID: 28600301 [TBL] [Abstract][Full Text] [Related]
16. Ranibizumab for myopic choroidal neovascularization. Ng DSC; Fung NSK; Yip FLT; Lai TYY Expert Opin Biol Ther; 2020 Dec; 20(12):1385-1393. PubMed ID: 33003962 [TBL] [Abstract][Full Text] [Related]